ArticleBMJ open gastroenterology2016

Top-down Infliximab Study in Kids with Crohn's disease (TISKids): an international multicentre randomised controlled trial.

M A Cozijnsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.